NIH Asks Court To Dismiss KEI CAR-T Licensing Lawsuit

June 8, 2018 at 6:32 PM

The National Institutes of Health is asking a federal court to dismiss a lawsuit brought by Knowledge Ecology International challenging the agency’s plan to issue Kite Pharma an exclusive license to a government-developed CAR-T cancer therapy.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

NIH Asks Court To Dismiss KEI CAR-T Licensing Lawsuit

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.